載入...
CRISPR/Cas9‐mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line
BACKGROUND: Serine‐arginine protein kinase (SRPK) is a regulator of alternative splicing events via phosphorylation of splicing factor proteins. Oncogenic roles of SRPK1 and SRPK2 have been reported in various types of cancer. To date, only SRPK1/2 specific inhibitors and small interfering RNA (siRN...
Na minha lista:
| 發表在: | Cancer Rep (Hoboken) |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941449/ https://ncbi.nlm.nih.gov/pubmed/32671994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1224 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|